Skip to content
Use caution Drug recall · FDA · Published February 12, 2015

Actavis Recalls Vancomycin Capsules Due to Subpotent Drug Hazard

Actavis Inc is recalling specific lots of Vancomycin Hydrochloride Capsules, USP 250 mg because they may be subpotent. Check lot numbers and expiration dates.

🇺🇸 FDA recall #D-0406-2015DrugActavis ›
Take action

Contact the company

Recalling firmActavis Inc400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Actavis Inc has recalled Vancomycin Hydrochloride Capsules, USP, 250 mg because the drug is subpotent. The recall affects 29,405 cartons distributed nationwide. Subpotent drugs may not provide the intended therapeutic effect for patients. Read more at govinfonow.com/recall/44961-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-2.

Source Summary by GovInfoNow · govinfonow.com/recall/44961-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-2 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0406-2015

Cite this page

“Actavis Recalls Vancomycin Capsules Due to Subpotent Drug Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44961-actavis-inc-recalls-vancomycin-hydrochloride-capsules-usp-250-mg-2. Based on FDA recall #D-0406-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0406-2015%22&limit=1).

Actavis Inc recalled Vancomycin Hydrochloride Capsules, USP, 250 mg due to subpotent drug hazards, the Food and Drug Administration said on Feb. 12, 2015. The recall affects 29,405 cartons distributed nationwide.

How to tell if you have it

  • Brand: Actavis
  • Product: Vancomycin Hydrochloride Capsules, USP, 250 mg
  • Packaging: 2 x 10 count blister pack
  • NDC: 0591-3561-15
  • Lot codes: 3109554 (Exp 3/31/2015), 3111457 (Exp 3/31/2015), 3112973 (Exp 7/31/2015), 3114262 (Exp 6/30/2015), 3114076 (Exp 12/31/2015), 3115889 (Exp 12/31/2015), 3116033 (Exp 12/31/2015)

The hazard

The recalled Vancomycin Hydrochloride Capsules are subpotent drugs. The FDA record does not report specific incidents or injuries associated with this recall.

Context

GovInfoNow's records show Actavis Inc has 13 other recalls on record since March 22, 2013. Other recent recalls of similar products include Actavis Levofloxacin Eye Drops Recall (Feb. 7, 2017), Actavis Glipizide 2.5mg Tablets Recall (Jan. 30, 2017), and Actavis Albuterol Inhaler Recall (Jan. 12, 2017). Other recent recalls of similar products include Baxter Vancomycin Injection Recalls (Aug. 6, 2026) and Teva Isotretinoin Capsules 30mg Recall (Jan. 12, 2026).

How to tell if you have this one

Look for Vancomycin Hydrochloride Capsules, USP, 250 mg in a 2 x 10 count blister pack, Rx Only, manufactured by Patheon Pharmaceuticals Inc. for Watson Pharma. Check the NDC 0591-3561-15 and one of the following lot numbers: 3109554 (Exp 3/31/2015), 3111457 (Exp 3/31/2015), 3112973 (Exp 7/31/2015), 3114262 (Exp 6/30/2015), 3114076 (Exp 12/31/2015), 3115889 (Exp 12/31/2015), or 3116033 (Exp 12/31/2015).

  • Brand
    Actavis
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantity
D-0396-2015Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3560-15; Lot #: 310935 Exp 3/31/2015; Lot #: 3109552 Exp 3/31/2015; Lot #: 3110204, Exp 3/31/2015; Lot #: 3112972, Exp 7/31/2015; Lot #: 3114073, Exp 8/31/2015; Lot #: 3115756, Exp 10/31/2015, Lot #: 3115888, Exp 10/31/2015; Lot #: 3118059, Exp 11/30/2015.51,472 cartons
D-0406-2015Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3561-15; Lot #: 3109554, Exp 3/31/2015; Lot #: 3111457, Exp 3/31/2015; Lot #: 3112973, Exp 7/31/2015; Lot #: 3114262, Exp 6/30/2015; Lot #: 3114076, Exp 12/31/2015; Lot #: 3115889, Exp 12/31/2015; Lot #: 3116033, Exp 12/31/2015.29,405 cartons
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    If you have the recalled product, contact your pharmacist or healthcare provider immediately to discuss alternative treatment options.

  2. Verify Lot Numbers

    Check the expiration date and lot number on your medication packaging against the list of recalled lots provided in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Feb 12, 201512. FDA classified it Class II: Mar 3, 201523. Published in FDA’s Enforcement Report: Mar 11, 201534. FDA terminated the recall: Dec 4, 201542015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0406-2015 (February 12, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0406-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA